Remove Biopharma Remove Patients Remove Pharmaceutical manufacturing Remove Prospecting
article thumbnail

AmerisourceBergen agrees to acquire PharmaLex for $1.29bn

Pharmaceutical Technology

The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product. Additionally, it aids clients in introducing products to international markets and varied patient populations by delivering tech-driven services spanning from clinical development consultation to marketing authorisation.